A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women

摘要

Background: Chinese women tend to have small and dense breasts and ultrasound is a common method for breast cancer screening in China. However, its efficacy and cost comparing with mammography has not been evaluated in randomised trials. Methods: At 14 breast centres across China during 2008–2010, 13?339 high-risk women aged 30–65 years were randomised to be screened by mammography alone, ultrasound alone, or by both methods at enrolment and 1-year follow-up. Results: A total of 12?519 and 8692 women underwent the initial and second screenings, respectively. Among the 30 cancers (of which 15 were stage 0/I) detected, 5 (0.72/1000) were in the mammography group, 11 (1.51/1000) in the ultrasound group, and 14 (2.02/1000) in the combined group ( P =0.12). In the combined group, ultrasound detected all the 14 cancers, whereas mammography detected 8, making ultrasound more sensitive (100 vs 57.1%, P =0.04) with a better diagnostic accuracy (0.999 vs 0.766, P =0.01). There was no difference between mammography and ultrasound in specificity (100 vs 99.9%, P =0.51) and positive predictive value (72.7 vs 70.0% P =0.87). To detect one cancer, the costs of ultrasound, mammography, and combined modality were $7876, $45?253, and $21?599, respectively. Conclusions: Ultrasound is superior to mammography for breast cancer screening in high-risk Chinese women.